Latest Sectors News
A noteworthy Canadian family has announced a profound C$10 million donation aimed at transforming the hospital landscape in Mississauga. This funding will kickstart a matching challenge designed to galvanize community support for the Built for Us initiative. Among its goals are major enhancements including the construction of the new Mississauga Hospital and Shah Family Hospital for Women and Children, furthering efforts to elevate regional healthcare facilities. View More
A noteworthy Canadian family has announced a profound C$10 million donation aimed at transforming the hospital landscape in Mississauga. This funding will kickstart a matching challenge designed to galvanize community support for the Built for Us initiative. Among its goals are major enhancements including the construction of the new Mississauga Hospital and Shah Family Hospital for Women and Children, furthering efforts to elevate regional healthcare facilities. View More
A noteworthy Canadian family has announced a profound C$10 million donation aimed at transforming the hospital landscape in Mississauga. This funding will kickstart a matching challenge designed to galvanize community support for the Built for Us initiative. Among its goals are major enhancements including the construction of the new Mississauga Hospital and Shah Family Hospital for Women and Children, furthering efforts to elevate regional healthcare facilities. View More
The National Company Law Tribunal (NCLT) invalidated a series of transactions involving JLS Realty Pvt Ltd, including the transfer of a prime redevelopment land parcel in Mumbai to Spenta Suncity and a mortgage and corporate guarantee linked to Rs 525 crore in financing involving IIFL.
In an order pronounced on October 23, the Mumbai bench of the tribunal also invalidated the appointment of two IIFL-linked employees as directors, declared the attempted removal of an existing director illegal, reversed disputed share transfers and ordered restoration of the company's land.
The Bench, comprising Judicial Member K R Saji Kumar and Technical Member Anil Raj Chellan, held that the sequence of events was "demonstrative of a deliberate design", constituting oppression marked by a "lack of probity and fair dealing".
The ruling follows five years of litigation initiated by Moniveda Consultants LLP and Rajat Jhunjhunwala against Shajas Developers, JLS Realty, and other respondents.
The dispu View More
A gym owner opened up about the expenses of running a premium fitness centre in Faridabad, Haryana. Despite earning almost ?20 lakh on an average in a month, he shared how much he takes home. View More
A Virginia court ruled that Gregory Black unlawfully occupied 30 acres owned by a charitable trust established by Kanu Gandhi’s widow. Black failed to prove his adverse possession claim and was ordered to remove his belongings, surrender the land, and pay $11,375 in guardian ad litem fees. View More
As hospitals grapple with soaring costs in drugs, supplies, and labor, the integration of AI emerges as a vital necessity. View More
Hospitals face rising drug, supply and labour expenses while demand for care continues to grow. In this environment, AI is no longer merely an innovation line item. It must become a balance-sheet strategy. The boardroom question is simple: Which costs will it reduce, which outcomes will it improve, and when will the benefits materialise? Start where the money leaks: the revenue cycle Revenue-cycle management offers some of AI’s most immediate opportunities: eligibility verification, clinical coding, prior authorisation, denial prediction and payment reconciliation. Agentic AI goes further than chatbots: governed software agents can coordinate tasks across systems, flag exceptions and prepare claims for human approval. India illustrates the scale. IRDAI data for FY2024–25 show Rs 1,32,488 crore in health claims, of which Rs 94,248 crore was paid; Rs 18,521 crore was disallowed under policy terms, Rs 11,412 crore repudiated and Rs 8,307 crore pending. AI can improve documentation and reduce preventable errors, but it cannot legitimately eliminate contractual exclusions or coverage limits. That distinction matters: better collections must not mean inappropriate billing. Live Events And the competitive pressure is real. As Reuters reported in March 2026, insurers and providers are both deploying AI in reimbursement disputes. Without common standards and auditable decisions, automation risks becoming an expensive “bot-versus-bot” contest. Buying back clinician time, not merely cutting jobs Clinical documentation is another major cost centre. A randomised UCLA trial involving 238 physicians found that one ambient AI scribe reduced time spent writing notes by 9.5% compared with usual care; a second tool produced no statistically significant benefit. Evidence, therefore, supports selective deployment, not universal promises. The return on AI scribes may emerge through lower burnout, improved retention, more patient-facing time and more complete records, not necessarily more consultations per hour. Hospitals should measure staff experience alongside productivity and safety. From hospital beds to intelligent capacity The greatest gains may come from using existing infrastructure better. AI can predict admissions, identify likely discharges 24–48 hours in advance, optimise operating-theatre schedules and flag deterioration before costly escalation. A theatre slot recovered or an avoidable hospital day prevented creates capacity without constructing another building. Yet every model needs local validation: false alarms can overwhelm clinical teams and poorly designed discharge incentives can compromise care. Non-labour costs are equally consequential. Forecasting can reduce drug expiry and emergency purchases; predictive maintenance can limit CT and MRI downtime; contract analytics can detect overpayments; and building systems can reduce energy consumption. These gains are less glamorous than diagnostic AI, but often easier to translate into operating cash flow. The new development: AI is becoming clinical infrastructure The US FDA reported more than 1,600 authorised AI-enabled medical devices by September 2026, spanning imaging, cardiovascular care and other specialties. This signals progress from experimental algorithms towards regulated clinical products, not proof that every deployment delivers savings. India has its own examples. Apollo Hospitals reported 20 clinical AI algorithms in FY2025–26 and more than 3.5 million patient API interactions across AI-led pathways, including discharge prediction, early-warning systems and risk assessment. Combined with the Ayushman Bharat Digital Mission’s interoperable data infrastructure, such capabilities could help smaller hospitals extend scarce specialist capacity-if integration, privacy and affordability are addressed. The next leap is multimodal and agentic AI: systems that combine notes, scans, laboratory results and operational data, then help coordinate follow-up, referrals and discharge. Their value lies not in replacing clinical judgement but in connecting fragmented workflows, with clinicians accountable for consequential decisions. Why the gap could become existential AI-enabled hospitals may collect faster, use beds more efficiently, attract digitally supported clinicians and offer patients clearer, quicker journeys. These advantages could influence investment and patient choice, although lower valuations for non-adopters are a risk, not an established universal rule. More importantly, the gap may compound as high-performing organisations improve their data quality and execution. Expectations, however, are ahead of evidence. Deloitte reports that 98% of surveyed healthcare executives anticipate at least 10% cost savings from agentic AI within two to three years, and 37% expect over 20%. Those are forecasts, not realised savings. Implementation costs, cybersecurity, bias, hallucinations, interoperability and ongoing model monitoring belong in every return-on-investment calculation. What boards should do now Start with six baselines: cost to collect, denial rate, length of stay, theatre utilisation, agency staffing costs and preventable adverse events. Select three high-value use cases; run controlled evaluations; calculate net savings after integration and oversight; and make vendor payments contingent on independently measured performance. Keep clinical safety, consent, auditability and human accountability non-negotiable. Hospitals that measure its impact on both patient outcomes and the balance sheet will be better placed to expand sustainable capacity. The real transformation in a hospital will be the one, that leverages AI to deliver better care with less waste. AI will not fix a broken business model on its own. But whether on a 1.4% margin in the US or with nearly a quarter of claim value going unpaid in India, every point it recovers decides whether a hospital attracts investment and patients, or loses both. Rajendra Pratap Gupta is the architect of the Functional AI Pyramid – AI Maturity Mode & the Theory of Technology Value and the three laws of elimination. He is building the hospital at the future at Global Digital Health Summit. .Pbanner{display:flex;justify-content:space-between;align-items:center;background-color:#ec1c40;margin-top:20px;padding:5px 10px;border-radius:4px;color:#fff;line-height:10px;width: 100%;box-sizing: border-box} .Pbannertext{display:flex;align-items:center;font-size:16px;font-weight:600;font-family:'Montserrat';} .Pbannertext img{height:20px;margin:0 6px} .Pbannerbutton a{display:flex;align-items:center;background-color:#fff;color:#ec1c40;text-decoration:none;font-weight:600;padding:4px 8px;border-radius:6px;font-size:15px;font-family:'Montserrat';} .Pbannerbutton img{height:20px;margin-right:6px} .Pbannerbutton a:hover{background-color:#f7f7f7} Add as a Reliable and Trusted News Source Add Now!
Ratnadeep Retail has received Sebi approval to launch an IPO comprising a fresh issue of up to Rs 400 crore and an offer for sale of 1.49 crore shares. The Hyderabad-based retailer plans to use part of the proceeds to repay borrowings and expand its store network across India. View More
Ratnadeep Retail, an organised food, grocery and value-fashion retailer, has received approval from the Securities and Exchange Board of India (SEBI) to raise funds through an initial public offering (IPO), according to an update on the capital markets regulator’s website on Friday. The proposed IPO of the Hyderabad-based company comprises a fresh issue of equity shares aggregating up to Rs 400 crore and an offer for sale (OFS) of up to 1.49 crore equity shares by the promoter selling shareholders, according to its draft red herring prospectus (DRHP). The company plans to utilise Rs 40 crore from the net proceeds of the fresh issue towards repayment or prepayment of certain borrowings. Another Rs 260 crore will be deployed towards expanding its retail footprint through the addition of new stores under the Ratnadeep and National Mart formats. The balance proceeds will be used for general corporate purposes. Motilal Oswal Investment Advisors, Axis Capital and DAM Capital Advisors are the book-running lead managers to the issue. ALSO READ: Record earnings! 5 big takeaways from RIL Q2 results investors should watch for Monday trading Live Events Ratnadeep Retail offers a diversified portfolio of more than 30,000 stock-keeping units (SKUs) across fresh produce, fast-moving consumer goods (FMCG), staples, general merchandise and apparel. Its product assortment caters to both essential and discretionary consumer spending. As of March 31, 2026, the company operated 190 stores across its two retail formats. Under the Ratnadeep brand, it operates 'Ratnadeep – Mindful Living', a neighbourhood supermarket format, and 'Ratnadeep Select', which focuses on premium food retailing. The company also operates National Mart, a value-led hypermarket chain that houses Style Mart, its affordable fashion retail offering. Ratnadeep Retail may also undertake a pre-IPO placement of equity shares aggregating up to Rs 80 crore, in consultation with the book-running lead managers, before filing the red herring prospectus with the Registrar of Companies (RoC). In the event of such a placement, the size of the fresh issue will be reduced by the amount raised. On the financial front, the company reported revenue from operations of Rs 2,223 crore in FY26, registering a compound annual growth rate (CAGR) of 15% since FY24. Its profit after tax (PAT) stood at Rs 36.7 crore during the fiscal. According to the DRHP, Avenue Supermarts , Vishal Mega Mart , Spencer's Retail and Trent are among the company's listed peers. Disclosure: This article has been written by Kumar Gaurav, who is not a Sebi-registered Research Analyst or an Investment Adviser. Gaurav and their ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective Sebi-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here .Pbanner{display:flex;justify-content:space-between;align-items:center;background-color:#ec1c40;margin-top:20px;padding:5px 10px;border-radius:4px;color:#fff;line-height:10px;width: 100%;box-sizing: border-box} .Pbannertext{display:flex;align-items:center;font-size:16px;font-weight:600;font-family:'Montserrat';} .Pbannertext img{height:20px;margin:0 6px} .Pbannerbutton a{display:flex;align-items:center;background-color:#fff;color:#ec1c40;text-decoration:none;font-weight:600;padding:4px 8px;border-radius:6px;font-size:15px;font-family:'Montserrat';} .Pbannerbutton img{height:20px;margin-right:6px} .Pbannerbutton a:hover{background-color:#f7f7f7} Add as a Reliable and Trusted News Source Add Now! (You can now subscribe to our ETMarkets WhatsApp channel) (You can now subscribe to our ETMarkets WhatsApp channel)
